NAGIOS: RODERIC FUNCIONANDO

Implant treatment in patients with osteoporosis

Repositori DSpace/Manakin

IMPORTANT: Aquest repositori està en una versió antiga des del 3/12/2023. La nova instal.lació está en https://roderic.uv.es/

Implant treatment in patients with osteoporosis

Mostra el registre parcial de l'element

dc.contributor.author Mellado Valero, Ana es
dc.contributor.author Ferrer García, Juan Carlos es
dc.contributor.author Calvo Catalá, Javier es
dc.contributor.author Labaig Rueda, Carlos es
dc.date.accessioned 2017-07-27T08:46:23Z
dc.date.available 2017-07-27T08:46:23Z
dc.date.issued 2010 es
dc.identifier.citation Mellado Valero, Ana ; Ferrer García, Juan Carlos ; Calvo Catalá, Javier ; Labaig Rueda, Carlos. Implant treatment in patients with osteoporosis. En: Medicina oral, patología oral y cirugía bucal. Ed. inglesa, 15 1 2010: 12- es
dc.identifier.uri http://hdl.handle.net/10550/60397
dc.description.abstract Osteoporosis is very common, particularly in post-menopausal women and is characterized by a decrease in bone mass and strength. Osteoporosis also affects the jawbone and it is considered a potential contraindication to placement of dental implants. The present paper reviews the literature regarding the effect of osteoporosis on osseointegration of implants. Experimental models have shown that osteoporosis affects the process of osseointegration, which can be reversed by treatment. However, studies in subjects with osteoporosis have shown no differences in survival of the implants compared to healthy individuals. Therefore, osteoporosis cannot be considered a contraindication for implant placement. Oral bisphosphonates are the most commonly used pharmacological agents in the treatment of osteoporosis. Although there have been cases of osteonecrosis of the jaw in patients treated with bisphosphonates, they are very rare and it is more usually associated with intravenous bisphosphonates in patients with neoplasms or other serious diseases. Nevertheless, patients treated with bisphosphonates must be informed in writing about the possibility of this complication and must give informed consent. Ceasing to use bisphosphonates before implant placement does not seem to be necessary. es
dc.title Implant treatment in patients with osteoporosis es
dc.type journal article es_ES
dc.subject.unesco UNESCO::CIENCIAS MÉDICAS es
dc.identifier.doi 10.4317/medoral.15.e52 es
dc.type.hasVersion VoR es_ES

Visualització       (289.0Kb)

Aquest element apareix en la col·lecció o col·leccions següent(s)

Mostra el registre parcial de l'element

Cerca a RODERIC

Cerca avançada

Visualitza

Estadístiques